Web Analytics

3 Latest Announced Rounds

  • $23,000,000
    Unknown

    3 Investors

    Data Infrastructure and Analytics
    May 8th, 2025
  • $39,000,000
    Series B

    2 Investors

    Biotechnology Research
    May 8th, 2025
  • $50,000,000
    Series A
    Personal Care Product Manufacturing
    May 8th, 2025
$499.26M Raised in 43 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Merida Biosciences

start up
  • 10/04/2025
  • Series A
  • $121,000,000

Merida Biosciences is a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate pathogenic antibodies that drive disease. The company is advancing a robust pipeline to precisely eliminate the root cause of multiple autoimmune and allergic conditions that are inadequately treated today. Its lead program is designed to specifically and rapidly clear the pathogenic autoantibodies that cause Graves' disease, an autoimmune disorder that affects the thyroid gland. Merida was publicly launched in April 2025 and is based in Cambridge, MA. For more information about Merida, visit www.meridabio.com.


Related People

Adam TownsendFounder

Adam Townsend United States - Greater Boston

N/A